Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study
Objective. This study aimed at investigating the therapeutic effect and mechanism of pioglitazone metformin complex preparation (PM) in polycystic ovary syndrome (PCOS) comorbid psychological distress. Methods. Seventy-five patients with PCOS comorbid psychological distress were randomly allocated i...
Saved in:
Main Authors: | Qing-jun Guo (Author), Jing Shan (Author), Yi-feng Xu (Author), Yan-yan Hu (Author), Cui-lan Huo (Author), Jing-yun Song (Author), Chao-qun Wang (Author), Hui Zhou (Author), Chao-qin Yu (Author), Qin Huang (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Histomorphological Comparative Effects of Metformin, Pioglitazone, Repaglinide and Acarbose on Polycystic Ovary in Mice
by: fariba noori, et al.
Published: (2020) -
Role of Metformin in Polycystic Ovary Syndrome
by: Karolina Nowak, et al.
Published: (2024) -
Effect of pioglitazone treatment on serum chemerin and vaspin levels in polycystic ovary syndrome.
by: Rana Hussein Kutaif, et al.
Published: (2022) -
Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
by: Han Zhao, et al.
Published: (2024) -
Rubus chingii Hu relieved the polycystic ovary syndrome with enhanced insulin sensitivity through inhibiting TXNIP/NLRP3 inflammasome signaling
by: Huizhen Li, et al.
Published: (2023)